NovaBay Pharmaceuticals, Inc. — Form D

NovaBay Pharmaceuticals, Inc. of EMERYVILLE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-08-26. The offering totals $4.2M, of which $4.2M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (58)

Showing 25 of 58 people.

NameRoleLocation
Gail MaderisDirectorRedwood City, CA
TODD ZAVODNICKDirectorEMERYVILLE, CA
JASON RALEIGHExecutive OfficerEMERYVILLE, CA
MIJIA (BOB) WUDirectorEMERYVILLE, CA
SWAN SITDirectorEMERYVILLE, CA
PAUL FREIMANDirectorEMERYVILLE, CA
JULIE GARLIKOVDirectorEMERYVILLE, CA
JUSTIN HALLDirectorEMERYVILLE, CA
JUSTIN HALLExecutive OfficerEMERYVILLE, CA
TOMMY LAWExecutive OfficerEMERYVILLE, CA
YENYOU (JEFF) ZHENGDirectorEMERYVILLE, CA
YONGXIANG (SEAN) ZHENGDirectorEMERYVILLE, CA
Andrew JonesExecutive OfficerRiverside, MO
JEFFREY KUNINExecutive OfficerKANSAS CITY, MO
AUDREY KUNINDirectorKANSAS CITY, MO
AUDREY KUNINExecutive OfficerKANSAS CITY, MO
Mark SieczkarekDirectorEl Segundo, CA
Gail E MaderisDirectorBerkeley, CA
YENYOU (JEFF) E ZHENGDirectorEMERYVILLE, CA
PAUL E FREIMANDirectorEMERYVILLE, CA
AUDREY M KUNINExecutive OfficerKANSAS CITY, MO
SWAN E SITDirectorEMERYVILLE, CA
XINZHOU (PAUL) E LIDirectorEMERYVILLE, CA
JEFFREY M KUNINExecutive OfficerKANSAS CITY, MO
MIJIA (BOB) E WUDirectorEMERYVILLE, CA

Other filings by this issuer (18)

Showing 15 of 18 filings.

FiledFormOfferingSold
2026-01-27D$134.0M$134.0M
2024-06-28D$226K$226K
2024-04-05D$665K$665K
2024-01-04D$555K$555K
2023-05-18D$3.0M$3.0M
2022-09-23D$3.3M$3.3M
2022-09-23D$2.1M$2.1M
2021-11-17D$15.0M$15.0M
2020-07-31D$6.8M
2020-05-22D$1.7M$1K
2020-05-01D
2019-08-26D$2.7M$2.7M
2019-07-03D$2.4M$2.4M
2018-02-14D$6.0M$6.0M
2016-05-20D$11.8M$7.8M

More